Federica Sepe: Are Biomarkers Finally Ready for Precision Stroke Medicine?
Federica Sepe, Neurologist at Bufalini Hospital, shared a post on LinkedIn about a recent article by Steffen Tiedt et al., published in The Lancet Neurology, adding:
“Are biomarkers finally ready for precision stroke medicine?
A new Lancet Neurology consensus review provides one of the most comprehensive roadmaps for translating stroke biomarkers into clinical practice. Rather than proposing another list of promising candidates, the authors define 17 research priorities and 5 minimum reporting datasets to improve standardization and accelerate clinical implementation.
Three key take-home messages:
- Blood, CSF and imaging biomarkers should be integrated rather than evaluated in isolation.
- Standardized reporting is essential to move from discovery to clinical adoption.
- Future precision stroke care will likely rely on multimodal models combining clinical variables, neuroimaging, AI and biomarkers.
My perspective
The next challenge is no longer identifying new biomarkers, but determining which combinations of biomarkers provide actionable clinical information for diagnosis, prognosis and treatment selection. Integrating artificial intelligence with multimoda.”
Title: Biomarkers for advancing diagnosis and prognosis in stroke
Authors: Steffen Tiedt, Alejandro Bustamante, Alan Cameron, Pol Camps-Renom, Gerrit M. Grosse, Johanna Ospel, Bastian Volbers, Heinrich J. Audebert, Julia Aulin, Bastian Cheng, Charlotte Cordonnier, Jonathan M. Coutinho, Ana Catarina Fonseca, Michael D. Hill, Märit Jensen, Christina Jern, Joseph Kamtchum-Tatuene, Mira Katan, Peter J. Kelly, Anna Kopczak, Robin Lemmens, Arne G. Lindgren, James J. M. Loan, Christian H. Nolte, Laurent Puy, Luca Saba, Rustam Al-Shahi Salman, Else Charlotte Sandset, Magdy H. Selim, Pierre Seners, Nikola Sprigg, Hsin-Hsi Tsai, Karen M. Doyle, Joan Montaner, Floris H. B. M. Schreuder, Luciano Sposato, Neshika Samarasekera, John J. McCabe
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke